These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22927529)

  • 1. Accumulating evidence for the effect of chemotherapy on cognition.
    Rodin G; Ahles TA
    J Clin Oncol; 2012 Oct; 30(29):3568-9. PubMed ID: 22927529
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive deficits are usually mild in patients with breast cancer after chemotherapy.
    Barton MK
    CA Cancer J Clin; 2013 Jan; 63(1):3-4. PubMed ID: 23169539
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort.
    Du XL; Xia R; Hardy D
    Am J Clin Oncol; 2010 Dec; 33(6):533-43. PubMed ID: 20023570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.
    Jansen CE; Miaskowski C; Dodd M; Dowling G
    Oncol Nurs Forum; 2005 Mar; 32(2):329-42. PubMed ID: 15759070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive problems after chemotherapy for breast cancer.
    Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB; van Dam FS
    J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
    Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
    Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.
    Maruff P; Falleti MG; Collie A
    Cancer; 2004 Nov; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092
    [No Abstract]   [Full Text] [Related]  

  • 11. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
    Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
    Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problem.
    Schott A; Hayes DF
    J Clin Oncol; 2004 Dec; 22(23):4660-2. PubMed ID: 15505274
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.
    Kreukels BP; Schagen SB; Ridderinkhof KR; Boogerd W; Hamburger HL; Muller MJ; van Dam FS
    Clin Breast Cancer; 2006 Apr; 7(1):67-78. PubMed ID: 16764746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is adjuvant chemotherapy useful for women with luminal a breast cancer?
    Coates AS; Colleoni M; Goldhirsch A
    J Clin Oncol; 2012 Apr; 30(12):1260-3. PubMed ID: 22355052
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
    Benson JR
    J Clin Oncol; 2005 Sep; 23(27):6807-9. PubMed ID: 16170197
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
    Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
    J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment, aromatase inhibitors, and age.
    Tralongo P; Di Mari A; Ferrau' F
    J Clin Oncol; 2005 Jun; 23(18):4243. PubMed ID: 15961782
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
    Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.